Aberdeen Group’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-169,023
| Closed | -$25.2M | – | 1046 |
|
|
2021
Q3 | $25.2M | Sell |
169,023
-41,794
| -20% | -$6.23M | 0.06% | 304 |
|
|
2021
Q2 | $51.6M | Sell |
210,817
-35,824
| -15% | -$8.77M | 0.11% | 177 |
|
|
2021
Q1 | $65.3M | Buy |
246,641
+1,733
| +0.7% | +$459K | 0.15% | 145 |
|
|
2020
Q4 | $71.9M | Buy |
244,908
+59,699
| +32% | +$17.5M | 0.18% | 122 |
|
|
2020
Q3 | $43.8M | Buy |
185,209
+70,305
| +61% | +$16.6M | 0.12% | 155 |
|
|
2020
Q2 | $22.8M | Buy |
114,904
+347
| +0.3% | +$68.9K | 0.06% | 275 |
|
|
2020
Q1 | $21M | Buy |
+114,557
| New | +$21M | 0.07% | 247 |
|